SELLAS Life Sciences Group, Inc. (SLS)
9.98
-1.36
(-11.99%)
USD |
NASDAQ |
Oct 16, 16:00
10.08
+0.10
(+1.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Net Income (TTM) : -32.46M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.46M |
| March 31, 2026 | -29.46M |
| December 31, 2025 | -26.86M |
| September 30, 2025 | -25.94M |
| June 30, 2025 | -26.26M |
| March 31, 2025 | -27.13M |
| December 31, 2024 | -30.88M |
| September 30, 2024 | -32.28M |
| June 30, 2024 | -34.44M |
| March 31, 2024 | -35.81M |
| December 31, 2023 | -37.34M |
| September 30, 2023 | -38.32M |
| June 30, 2023 | -36.08M |
| March 31, 2023 | -35.65M |
| December 31, 2022 | -41.30M |
| September 30, 2022 | -38.78M |
| June 30, 2022 | -38.84M |
| March 31, 2022 | -35.04M |
| December 31, 2021 | -20.70M |
| September 30, 2021 | -17.82M |
| June 30, 2021 | -15.20M |
| March 31, 2021 | -15.02M |
| December 31, 2020 | -16.76M |
| September 30, 2020 | -12.04M |
| June 30, 2020 | -19.04M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.70M |
| December 31, 2019 | -19.54M |
| September 30, 2019 | -33.86M |
| June 30, 2019 | -23.17M |
| March 31, 2019 | -27.61M |
| December 31, 2018 | -32.60M |
| September 30, 2018 | -27.45M |
| June 30, 2018 | -31.12M |
| March 31, 2018 | -28.51M |
| December 31, 2017 | -23.15M |
| September 30, 2017 | -16.90M |
| June 30, 2017 | -16.79M |
| March 31, 2017 | -2.60M |
| December 31, 2016 | -11.10M |
| September 30, 2016 | -19.97M |
| June 30, 2016 | -21.98M |
| March 31, 2016 | -45.92M |
| December 31, 2015 | -43.36M |
| September 30, 2015 | -40.50M |
| June 30, 2015 | -40.33M |
| March 31, 2015 | -44.61M |
| December 31, 2014 | -36.61M |
| September 30, 2014 | -77.15M |
| June 30, 2014 | -80.26M |
| March 31, 2014 | -69.92M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AbbVie, Inc. | 6.274B |
| ImmunityBio, Inc. | -992.42M |
| TG Therapeutics, Inc. | 441.49M |
| Capricor Therapeutics, Inc. | -129.42M |
| Relay Therapeutics, Inc. | -286.04M |